149 related articles for article (PubMed ID: 23811795)
1. N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.
Liu J; Liu H; Zhang W; Wu Q; Liu W; Liu Y; Pan D; Xu J; Gu J
Glycobiology; 2013 Sep; 23(9):1097-109. PubMed ID: 23811795
[TBL] [Abstract][Full Text] [Related]
2. Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma.
Chen L; Liu H; Liu J; Zhu Y; Xu L; He H; Zhang H; Wang S; Wu Q; Liu W; Liu Y; Pan D; Ren S; Xu J; Gu J
PLoS One; 2013; 8(3):e58413. PubMed ID: 23516476
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1.
Xu J; Liu H; Chen L; Wang S; Zhou L; Yun X; Sun L; Wen Y; Gu J
Gastroenterology; 2012 Jul; 143(1):199-212.e4. PubMed ID: 22484303
[TBL] [Abstract][Full Text] [Related]
4. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
[TBL] [Abstract][Full Text] [Related]
5. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
6. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.
Fuchs BC; Fujii T; Dorfman JD; Goodwin JM; Zhu AX; Lanuti M; Tanabe KK
Cancer Res; 2008 Apr; 68(7):2391-9. PubMed ID: 18381447
[TBL] [Abstract][Full Text] [Related]
8. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase pathway is pivotal for anoikis resistance in metastatic hepatoma cells.
Cao L; Zhang Z; Han L; Du J; Liang X; Liu Y; Sun W
Mol Med Rep; 2014 Apr; 9(4):1121-7. PubMed ID: 24535322
[TBL] [Abstract][Full Text] [Related]
10. Complex N-glycan and metabolic control in tumor cells.
Mendelsohn R; Cheung P; Berger L; Partridge E; Lau K; Datti A; Pawling J; Dennis JW
Cancer Res; 2007 Oct; 67(20):9771-80. PubMed ID: 17942907
[TBL] [Abstract][Full Text] [Related]
11. Involvement of alpha-PAK-interacting exchange factor in the PAK1-c-Jun NH(2)-terminal kinase 1 activation and apoptosis induced by benzo[a]pyrene.
Yoshii S; Tanaka M; Otsuki Y; Fujiyama T; Kataoka H; Arai H; Hanai H; Sugimura H
Mol Cell Biol; 2001 Oct; 21(20):6796-807. PubMed ID: 11564864
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.
Tang W; Feng X; Zhang S; Ren Z; Liu Y; Yang B; lv B; Cai Y; Xia J; Ge N
Cell Physiol Biochem; 2015; 36(3):1223-36. PubMed ID: 26138883
[TBL] [Abstract][Full Text] [Related]
13. EGF-mediated migration signaling activated by N-acetylglucosaminyltransferase-V via receptor protein tyrosine phosphatase kappa.
Wang C; Yang Y; Yang Z; Liu M; Li Z; Sun L; Mei C; Chen H; Chen L; Wang L; Zha X
Arch Biochem Biophys; 2009 Jun; 486(1):64-72. PubMed ID: 19236842
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling.
Li J; Yang XM; Wang YH; Feng MX; Liu XJ; Zhang YL; Huang S; Wu Z; Xue F; Qin WX; Gu JR; Xia Q; Zhang ZG
J Hepatol; 2014 Jun; 60(6):1225-34. PubMed ID: 24607627
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of N-acetylglucosaminyltransferase-V by heparin-binding EGF-like growth factor induces keratinocyte proliferation and epidermal hyperplasia.
Kimura A; Terao M; Kato A; Hanafusa T; Murota H; Katayama I; Miyoshi E
Exp Dermatol; 2012 Jul; 21(7):515-9. PubMed ID: 22716246
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
[TBL] [Abstract][Full Text] [Related]
18. Active p21-activated kinase 1 rescues MCF10A breast epithelial cells from undergoing anoikis.
Menard RE; Jovanovski AP; Mattingly RR
Neoplasia; 2005 Jul; 7(7):638-45. PubMed ID: 16026643
[TBL] [Abstract][Full Text] [Related]
19. Lectin from Sambucus sieboldiana abrogates the anoikis resistance of colon cancer cells conferred by N-acetylglucosaminyltransferase V during hematogenous metastasis.
Song KJ; Jeon SK; Moon SB; Park JS; Kim JS; Kim J; Kim S; An HJ; Ko JH; Kim YS
Oncotarget; 2017 Jun; 8(26):42238-42251. PubMed ID: 28178684
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
